Edesa Biotech Inc. (EDSA) is a clinical-stage biopharmaceutical firm based in Markham, Canada, dedicated to developing advanced therapies for inflammatory and immune-related disorders. The company boasts a promising pipeline that leverages proprietary technologies to enhance treatment options, particularly in dermatological and gastrointestinal diseases, addressing critical unmet medical needs. With several ongoing clinical trials and a strong emphasis on improving patient outcomes, Edesa is strategically positioned to make significant advancements in the biotherapeutics arena, aiming to expand its influence within the healthcare sector. Show more

Location: 100 SPY COURT, MARKHAM, ON, CANADA, L3R 5H6, Markham, ON, L3R 5H6, USA | Website: https://www.edesabiotech.com | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

9.751M

52 Wk Range

$1.09 - $4.49

Previous Close

$1.23

Open

$1.24

Volume

272,743

Day Range

$1.09 - $1.25

Enterprise Value

9.233M

Cash

10.79M

Avg Qtr Burn

-1.766M

Insider Ownership

16.93%

Institutional Own.

34.42%

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.